Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Specialised Therapeutics Asia to License Promising Anti-Cancer Compound Lurbinectedin (PM1183) for South East Asia, Australia and New Zealand 2017-05-18 00:23
China Pharma Holdings, Inc.'s Wholly-owned Subsidiary Participated in PharmChina/API China Conferences 2017-05-17 20:30
Sinovac Biotech Announces Receipt of NASDAQ Letter and Delayed Filing of Annual Report on Form 20-F 2017-05-17 04:00
Shineco, Inc. Reports Third Quarter of 2017 Financial Results 2017-05-16 05:30
Saikang Medical to Participate in FIME 2017 2017-05-15 21:15
China Pharma Holdings, Inc. Reports First Quarter 2017 Financial Results 2017-05-12 18:00
Shineco, Inc. Retains Ascent Investor Relations LLC 2017-05-11 20:00
VolitionRx Limited Announces First Quarter 2017 Financial Results and Business Update 2017-05-11 18:30
Lianluo Smart Declares its Proposals for AGM 2017-05-10 20:00
Initial Pre-Emergency Use Authorization Submission Made to U.S. FDA for Use of ReCell® in a Mass Casualty Scenario 2017-05-10 18:00
Adimmune's Quadrivalent Flu Vaccine Approved by TFDA 2017-05-10 17:46
VolitionRx Limited Announces Final Results from 8000 Patient Clinical Trial in Denmark to Evaluate the Performance of its Nu.Q(TM) Triage Test 2017-05-09 19:30
VolitionRx Limited Schedules First Quarter 2017 Earnings Conference Call and Business Update 2017-05-08 20:00
CPHI to Hold First Quarter 2017 Earnings Conference Call On Friday May 12, 2017 at 8:30 a.m. ET 2017-05-08 18:00
Lianluo Smart Announces Annual General Meeting Time 2017-05-04 20:00
China Biologic Reports Financial Results for the First Quarter of 2017 2017-05-04 04:45
IMPACT Received IMP4297 Chinese IND Approval 2017-05-03 20:50
CARsgen Therapeutics Opens CAR T-cell Manufacturing Facility in Shanghai 2017-05-03 19:15
USANA Celebrates Longevity and Success in Malaysia 2017-05-03 02:11
Concord Medical Files 2016 Annual Report on Form 20-F 2017-05-02 17:00
1 331 332 333 334 335 800